Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins

This validation study investigates the use of circulating protein biomarkers to improve lung cancer risk assessment and eligibility criteria for screening with low-dose computed tomography.

https://ift.tt/2L8xJH4